iZafe Group

iZafe Group FCF Yield

The Free Cash Flow Yield of iZafe Group (IZAFE B.ST) as of Nov 19, 2026 is -21.04 %. In the previous year, Free Cash Flow Yield was -8.94 % — a change of 135.22% (lower).

FCF Yield

-21.04 %

YoY

135.22%

Last updated:

Free Cash Flow Yield of iZafe Group is 2025 -21.04 % . Free Cash Flow Yield of iZafe Group was 2024 -8.94 % . It decreases by 135.22% lower compared to the previous year.

The iZafe Group FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-16.59 SEK
Jan 1, 2019
-14.08 SEK
Jan 1, 2020
-18.89 SEK
Jan 1, 2021
-24.35 SEK
Jan 1, 2022
-17.42 SEK
Jan 1, 2023
-9.18 SEK
Jan 1, 2024
-8.94 SEK
Jan 1, 2025
-21.04 SEK
The iZafe Group FCF Yield history
YEARFCF YieldYoY
-21.04 %+135.22%
-8.94 %-2.64%
-9.18 %-47.28%
-17.42 %-28.45%
-24.35 %+28.92%
-18.89 %+34.15%
-14.08 %-15.15%
-16.59 %+137.04%
-7.00 %+77.99%
-3.93 %+204.06%
-1.29 %+104.94%
-0.63 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

Free Cash Flow Yield of iZafe Group is -21.04 % in 2025.

Free Cash Flow Yield of iZafe Group changed from -8.94 % to -21.04 %, representing a 135.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield iZafe Group since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's iZafe Group with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — iZafe Group

All Key Metrics — iZafe Group